Literature DB >> 18321815

Uveal vs. cutaneous melanoma. Origins and causes of the differences.

Carolina Belmar-Lopez1, Pablo Mancheno-Corvo, Maria Antonia Saornil, Patrick Baril, Georges Vassaux, Miguel Quintanilla, Pilar Martin-Duque.   

Abstract

Melanoma is a malignant tumour derived from melanocytes (dendritic cells originated from the neural crest and capable to produce melanin synthesis) that could be established on the skin or less frequently on the uvea. The cellular origin from both kind of melanoma seems to be the same but the melanocytes migrates to the epithelia for cutaneous melanoma, while for uveal melanoma, they migrate to mesodermic tissues. Despite the common origin, both melanomas show extreme differences in their metastatic potential, clinical response to treatments, immune response and genetic alterations. We will describe some of those differences in this review.

Entities:  

Mesh:

Year:  2008        PMID: 18321815     DOI: 10.1007/s12094-008-0170-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  58 in total

Review 1.  PTEN function in normal and neoplastic growth.

Authors:  Lionel M L Chow; Suzanne J Baker
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

2.  Control of neural crest cell fate by the Wnt signalling pathway.

Authors:  R I Dorsky; R T Moon; D W Raible
Journal:  Nature       Date:  1998-11-26       Impact factor: 49.962

3.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

4.  Immunophenotypic differences between uveal and cutaneous melanomas.

Authors:  Satori Iwamoto; Robert C Burrows; Robert E Kalina; David George; Michael Boehm; Mark A Bothwell; Rodney Schmidt
Journal:  Arch Ophthalmol       Date:  2002-04

5.  Dominant role of the niche in melanocyte stem-cell fate determination.

Authors:  Emi K Nishimura; Siobhán A Jordan; Hideo Oshima; Hisahiro Yoshida; Masatake Osawa; Mariko Moriyama; Ian J Jackson; Yann Barrandon; Yoshiki Miyachi; Shin-Ichi Nishikawa
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

6.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

7.  Graded potential of neural crest to form cornea, sensory neurons and cartilage along the rostrocaudal axis.

Authors:  Peter Y Lwigale; Gary W Conrad; Marianne Bronner-Fraser
Journal:  Development       Date:  2004-03-31       Impact factor: 6.868

8.  Integrative genomic analysis of aneuploidy in uveal melanoma.

Authors:  Justis P Ehlers; Lori Worley; Michael D Onken; J William Harbour
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

Review 9.  The mechanisms of UV radiation in the development of malignant melanoma.

Authors:  Mirna Situm; Marija Buljan; Suzana Otanić Bulić; Dubravka Simić
Journal:  Coll Antropol       Date:  2007-01

Review 10.  Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.

Authors:  M Mimeault; R Hauke; P P Mehta; S K Batra
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

View more
  8 in total

Review 1.  Dormancy of metastatic melanoma.

Authors:  Liliana Ossowski; Julio A Aguirre-Ghiso
Journal:  Pigment Cell Melanoma Res       Date:  2009-10-19       Impact factor: 4.693

2.  Increased expression of hypoxia-inducible factor-1 alpha and its impact on transcriptional changes and prognosis in malignant tumours of the ocular adnexa.

Authors:  Clemens Alexander Klaus Lange; Patrick Lehnert; Stefaniya Konstantinova Boneva; Peipei Zhang; Franziska Ludwig; Martin Boeker; Klaus Hoffmeier; Ralf Horres; Günther Schlunck; Thomas Reinhard; Daniel Böhringer; Claudia Auw-Haedrich
Journal:  Eye (Lond)       Date:  2018-07-31       Impact factor: 3.775

3.  Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2.

Authors:  Hong Zhang; Zhilin Luo; JianMing Tang; Jie Tian; Yajie Xiao; Chao Sun; Tianhu Wang
Journal:  Cell Cycle       Date:  2022-01-05       Impact factor: 4.534

Review 4.  Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

5.  Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.

Authors:  K Strobel; B Bode; R Dummer; P Veit-Haibach; D R Fischer; L Imhof; S Goldinger; Hans C Steinert; G K von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-04       Impact factor: 9.236

6.  Risk Factors and Relationship of Cutaneous and Uveal Melanocytic Lesions in Monozygotic and Dizygotic Twin Pairs.

Authors:  Renáta Zsanett Csoma; Edit Tóth-Molnár; Anita Varga; Hajnalka Szabó; Hajnalka Orvos; Lajos Kemény; Judit Oláh
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

7.  Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.

Authors:  Aamir Zainulabadeen; Philip Yao; Habil Zare
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

8.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.